Video

Dr. Danciu on Prescreening and Identifying Breast Cancer Survivors

Oana C. Danciu, MD, assistant professor of Medicine, Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, discusses a study examining a team-based approach to prescreen and identify breast cancer survivors using a survivorship care plan.

Oana C. Danciu, MD, assistant professor of Medicine, Division of Hematology/Oncology, University of Illinois Hospital and Health Sciences System, discusses a study examining a team-based approach to prescreen and identify breast cancer survivors using a survivorship care plan.

Previously, the multidisciplinary approach of a survivorship care plan was reaching 25% of patients at the University of Illinois, Danciu explains. However, the goal was to reach 100%. Therefore, the team prescreened patients and identified those who qualified as survivors; survivors were defined as patients who completed their active treatments.

The clinic was able to reach above 90% compliance with the new team-based approach. Most recently, the University of Illinois has established a breast cancer survivorship clinic, where oncologists discuss survivorship issues and review care plans and treatment summaries. Danciu predicts this will help the clinic reach 100% compliance.

Related Videos
Christina Poh, MD
Mikkael A. Sekeres, MD, discusses the results of combining luspatercept and lenalidomide in lower-risk, non–5q deletion myelodysplastic syndromes.
David Samuel Dicapua Siegel, MD
Laahn Foster, MD
Christine Mauz-Koerholz, MD, PhD
Marcella Ali Kaddoura, MD
Wojciech Jurczak, MD, PhD
Muhamed Baljevic, MD, FACP and Jorge Cortes, MD, discuss upcoming studies and emerging data being presented at the 2024 ASH Annual Meeting.
Stephen V. Liu, MD